An Analysis of Persistent Symptoms in Acid-Suppressed Patients Undergoing Impedance-pH Monitoring

Neeraj Sharma, Amit Agrawal, Janice Freeman, Marcelo F. Vela, Donald Castell

Research output: Contribution to journalArticle

92 Citations (Scopus)

Abstract

Background & Aims: Despite proton-pump inhibitors (PPIs), patients may have persistent symptoms of gastroesophageal reflux disease (GERD). We aimed to identify symptom types and frequency experienced by patients on PPI therapy, and to identify the type of reflux, if any, associated with these symptoms. Methods: A retrospective review was performed of 200 patients on PPI with GERD symptoms during ambulatory impedance-pH testing. The symptom index (SI) was determined for each symptom, and an SI of 50% or more was considered positive. Patients were divided into 2 groups: those with exclusively nonacid reflux (NAR) episodes and those with mixed-acid and NAR episodes. Symptom profiles were compared between these 2 groups. Results: A total of 415 symptoms were reported by the 200 patients on twice-daily PPIs. Throat clearing was most common (24%). A total of 110 (27%) were typical symptoms and 305 (73%) were atypical. Typical symptoms were more likely to have a positive SI than atypical symptoms (48% vs 25%, P < .01). Eighty-four patients (42%) had a positive SI, and 116 patients (58%) had a negative SI. One hundred patients (50%) had only NAR; the other 100 had mixed acid and NAR. Heartburn (21% vs 63%, P < .01) and nausea (8% vs 44%, P < .01) were more likely associated with reflux in the mixed-acid and NAR group. Conclusions: Patients on PPIs still experience GERD symptoms. Impedance-pH monitoring identifies similar symptom associations with all types of reflux and also clarifies symptoms not related to any reflux.

Original languageEnglish (US)
Pages (from-to)521-524
Number of pages4
JournalClinical Gastroenterology and Hepatology
Volume6
Issue number5
DOIs
StatePublished - May 2008
Externally publishedYes

Fingerprint

Electric Impedance
Proton Pump Inhibitors
Acids
Gastroesophageal Reflux
Heartburn
Pharynx
Nausea

ASJC Scopus subject areas

  • Gastroenterology

Cite this

An Analysis of Persistent Symptoms in Acid-Suppressed Patients Undergoing Impedance-pH Monitoring. / Sharma, Neeraj; Agrawal, Amit; Freeman, Janice; Vela, Marcelo F.; Castell, Donald.

In: Clinical Gastroenterology and Hepatology, Vol. 6, No. 5, 05.2008, p. 521-524.

Research output: Contribution to journalArticle

Sharma, Neeraj ; Agrawal, Amit ; Freeman, Janice ; Vela, Marcelo F. ; Castell, Donald. / An Analysis of Persistent Symptoms in Acid-Suppressed Patients Undergoing Impedance-pH Monitoring. In: Clinical Gastroenterology and Hepatology. 2008 ; Vol. 6, No. 5. pp. 521-524.
@article{cb20f93cd45142049970c00692c5e028,
title = "An Analysis of Persistent Symptoms in Acid-Suppressed Patients Undergoing Impedance-pH Monitoring",
abstract = "Background & Aims: Despite proton-pump inhibitors (PPIs), patients may have persistent symptoms of gastroesophageal reflux disease (GERD). We aimed to identify symptom types and frequency experienced by patients on PPI therapy, and to identify the type of reflux, if any, associated with these symptoms. Methods: A retrospective review was performed of 200 patients on PPI with GERD symptoms during ambulatory impedance-pH testing. The symptom index (SI) was determined for each symptom, and an SI of 50{\%} or more was considered positive. Patients were divided into 2 groups: those with exclusively nonacid reflux (NAR) episodes and those with mixed-acid and NAR episodes. Symptom profiles were compared between these 2 groups. Results: A total of 415 symptoms were reported by the 200 patients on twice-daily PPIs. Throat clearing was most common (24{\%}). A total of 110 (27{\%}) were typical symptoms and 305 (73{\%}) were atypical. Typical symptoms were more likely to have a positive SI than atypical symptoms (48{\%} vs 25{\%}, P < .01). Eighty-four patients (42{\%}) had a positive SI, and 116 patients (58{\%}) had a negative SI. One hundred patients (50{\%}) had only NAR; the other 100 had mixed acid and NAR. Heartburn (21{\%} vs 63{\%}, P < .01) and nausea (8{\%} vs 44{\%}, P < .01) were more likely associated with reflux in the mixed-acid and NAR group. Conclusions: Patients on PPIs still experience GERD symptoms. Impedance-pH monitoring identifies similar symptom associations with all types of reflux and also clarifies symptoms not related to any reflux.",
author = "Neeraj Sharma and Amit Agrawal and Janice Freeman and Vela, {Marcelo F.} and Donald Castell",
year = "2008",
month = "5",
doi = "10.1016/j.cgh.2008.01.006",
language = "English (US)",
volume = "6",
pages = "521--524",
journal = "Clinical Gastroenterology and Hepatology",
issn = "1542-3565",
publisher = "W.B. Saunders Ltd",
number = "5",

}

TY - JOUR

T1 - An Analysis of Persistent Symptoms in Acid-Suppressed Patients Undergoing Impedance-pH Monitoring

AU - Sharma, Neeraj

AU - Agrawal, Amit

AU - Freeman, Janice

AU - Vela, Marcelo F.

AU - Castell, Donald

PY - 2008/5

Y1 - 2008/5

N2 - Background & Aims: Despite proton-pump inhibitors (PPIs), patients may have persistent symptoms of gastroesophageal reflux disease (GERD). We aimed to identify symptom types and frequency experienced by patients on PPI therapy, and to identify the type of reflux, if any, associated with these symptoms. Methods: A retrospective review was performed of 200 patients on PPI with GERD symptoms during ambulatory impedance-pH testing. The symptom index (SI) was determined for each symptom, and an SI of 50% or more was considered positive. Patients were divided into 2 groups: those with exclusively nonacid reflux (NAR) episodes and those with mixed-acid and NAR episodes. Symptom profiles were compared between these 2 groups. Results: A total of 415 symptoms were reported by the 200 patients on twice-daily PPIs. Throat clearing was most common (24%). A total of 110 (27%) were typical symptoms and 305 (73%) were atypical. Typical symptoms were more likely to have a positive SI than atypical symptoms (48% vs 25%, P < .01). Eighty-four patients (42%) had a positive SI, and 116 patients (58%) had a negative SI. One hundred patients (50%) had only NAR; the other 100 had mixed acid and NAR. Heartburn (21% vs 63%, P < .01) and nausea (8% vs 44%, P < .01) were more likely associated with reflux in the mixed-acid and NAR group. Conclusions: Patients on PPIs still experience GERD symptoms. Impedance-pH monitoring identifies similar symptom associations with all types of reflux and also clarifies symptoms not related to any reflux.

AB - Background & Aims: Despite proton-pump inhibitors (PPIs), patients may have persistent symptoms of gastroesophageal reflux disease (GERD). We aimed to identify symptom types and frequency experienced by patients on PPI therapy, and to identify the type of reflux, if any, associated with these symptoms. Methods: A retrospective review was performed of 200 patients on PPI with GERD symptoms during ambulatory impedance-pH testing. The symptom index (SI) was determined for each symptom, and an SI of 50% or more was considered positive. Patients were divided into 2 groups: those with exclusively nonacid reflux (NAR) episodes and those with mixed-acid and NAR episodes. Symptom profiles were compared between these 2 groups. Results: A total of 415 symptoms were reported by the 200 patients on twice-daily PPIs. Throat clearing was most common (24%). A total of 110 (27%) were typical symptoms and 305 (73%) were atypical. Typical symptoms were more likely to have a positive SI than atypical symptoms (48% vs 25%, P < .01). Eighty-four patients (42%) had a positive SI, and 116 patients (58%) had a negative SI. One hundred patients (50%) had only NAR; the other 100 had mixed acid and NAR. Heartburn (21% vs 63%, P < .01) and nausea (8% vs 44%, P < .01) were more likely associated with reflux in the mixed-acid and NAR group. Conclusions: Patients on PPIs still experience GERD symptoms. Impedance-pH monitoring identifies similar symptom associations with all types of reflux and also clarifies symptoms not related to any reflux.

UR - http://www.scopus.com/inward/record.url?scp=42749087698&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=42749087698&partnerID=8YFLogxK

U2 - 10.1016/j.cgh.2008.01.006

DO - 10.1016/j.cgh.2008.01.006

M3 - Article

C2 - 18356117

AN - SCOPUS:42749087698

VL - 6

SP - 521

EP - 524

JO - Clinical Gastroenterology and Hepatology

JF - Clinical Gastroenterology and Hepatology

SN - 1542-3565

IS - 5

ER -